The efficacy of rituximab in patients with chronic immune thrombocytopenic purpura. A single-centre experience

被引：0
|
作者：
Davis, Sarah [1 ]
Gamadia, Shireen [1 ]
机构：
[1] Milton Keynes Univ Hosp, Milton Keynes, Bucks, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH23-EP44
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [31] AN EXPERIENCE WITH LOW DOSE RITUXIMAB FOR THE TREATMENT OF PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA: A RETROSPECTIVE ANALYSIS OF SIX PATIENTS
    Raza, K.
    Murphy, P.
    Quinn, J.
    Thornton, P.
    HAEMATOLOGICA, 2012, 97 : 683 - 683
  • [32] Rituximab in three cases of refractory thrombotic thrombocytopenic purpura.
    Alcaraz, J
    González-García, C
    Majado, MJ
    Pérez, R
    Molina, JA
    Tamayo, M
    Moreno, M
    Morales, A
    BLOOD, 2005, 106 (11) : 82B - 82B
  • [33] Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura
    Sun, Lova
    Mack, Johnathan
    Li, Ang
    Ryu, Justine
    Upadhyay, Vivek A.
    Uhl, Lynne
    Kaufman, Richard M.
    Stowell, Christopher P.
    Dzik, Walter S.
    Makar, Robert S.
    Bendapudi, Pavan K.
    BLOOD ADVANCES, 2019, 3 (09) : 1512 - 1518
  • [34] Chronic immune thrombocytopenic purpura in children: Assessment of rituximab treatment
    Wang, J
    Wiley, JM
    Luddy, R
    Greenberg, J
    Feuerstein, MA
    Bussel, JB
    JOURNAL OF PEDIATRICS, 2005, 146 (02): : 217 - 221
  • [35] Single Centre UK Comparison of Biosimilar Rituximab (Truxima) with the Originator (MabThera) in Patients with Immune Mediated Thrombotic Thrombocytopenic Purpura
    Stubbs, Matthew J.
    Low, Ryan
    McGuckin, Siobhan
    Newton, Rosalind
    Westwood, John-Paul
    Thomas, Mari
    Cheesman, Simon
    Scully, Marie
    BLOOD, 2018, 132
  • [36] Acquired Thrombotic Thrombocytopenic Purpura - Single Centre Experience
    Alkindi, Fatima
    Boobes, Yousef
    Osman, Hani
    Hussain, Sabir
    Lal, Amar
    Syed, Masood
    Alam, Arif
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 220 - 221
  • [37] Is Splenectomy Necessary for Immune Thrombocytopenic Purpura? The Role of Rituximab in Patients With Corticosteroid Resistance in a Single-Center Experience
    Zhang, Cheng
    Liu, Huan-Feng
    Chen, Xing-Hua
    Gao, Lei
    Gao, Li
    Liu, Yao
    Kong, Pei-Yan
    Sun, Ai-Hua
    Zhang, Xi
    CLINICAL THERAPEUTICS, 2014, 36 (03) : 385 - 388
  • [38] Long term outcome of patients undergoing splenectomy for immune thrombocytopenic purpura.
    Novitzky, N
    Seth, Y
    Mothupi, R
    BLOOD, 2004, 104 (11) : 70B - 70B
  • [39] Retrospective study of 207 patients with immune thrombocytopenic purpura. The role of splenectomy
    Terruzzi, E.
    Rossini, F.
    Scollo, C.
    Verga, L.
    Pogliani, E. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 129 - 129
  • [40] Treatment of the Chronic Immune Thrombocytopenic Purpura. Looking for something better. Review
    Vizcaino, Gilberto
    Diez-Ewald, Maria
    Vizcaino-Carruyo, Jennifer
    INVESTIGACION CLINICA, 2009, 50 (01): : 95 - 108
12345